1. Home
  2. FEDU vs LEXX Comparison

FEDU vs LEXX Comparison

Compare FEDU & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEDU
  • LEXX
  • Stock Information
  • Founded
  • FEDU 2007
  • LEXX 2004
  • Country
  • FEDU China
  • LEXX Canada
  • Employees
  • FEDU N/A
  • LEXX N/A
  • Industry
  • FEDU
  • LEXX Biotechnology: Pharmaceutical Preparations
  • Sector
  • FEDU
  • LEXX Health Care
  • Exchange
  • FEDU NYSE
  • LEXX Nasdaq
  • Market Cap
  • FEDU 19.9M
  • LEXX 20.9M
  • IPO Year
  • FEDU 2017
  • LEXX N/A
  • Fundamental
  • Price
  • FEDU $9.76
  • LEXX $1.02
  • Analyst Decision
  • FEDU
  • LEXX Strong Buy
  • Analyst Count
  • FEDU 0
  • LEXX 1
  • Target Price
  • FEDU N/A
  • LEXX $7.00
  • AVG Volume (30 Days)
  • FEDU 2.0K
  • LEXX 90.9K
  • Earning Date
  • FEDU 06-26-2025
  • LEXX 07-11-2025
  • Dividend Yield
  • FEDU 23.36%
  • LEXX N/A
  • EPS Growth
  • FEDU N/A
  • LEXX N/A
  • EPS
  • FEDU 0.12
  • LEXX N/A
  • Revenue
  • FEDU $27,971,139.00
  • LEXX $525,923.00
  • Revenue This Year
  • FEDU N/A
  • LEXX $0.62
  • Revenue Next Year
  • FEDU N/A
  • LEXX $14.19
  • P/E Ratio
  • FEDU $81.89
  • LEXX N/A
  • Revenue Growth
  • FEDU 141.14
  • LEXX 29.95
  • 52 Week Low
  • FEDU $3.69
  • LEXX $0.95
  • 52 Week High
  • FEDU $22.70
  • LEXX $4.44
  • Technical
  • Relative Strength Index (RSI)
  • FEDU 71.40
  • LEXX 40.33
  • Support Level
  • FEDU $9.41
  • LEXX $1.00
  • Resistance Level
  • FEDU $9.76
  • LEXX $1.05
  • Average True Range (ATR)
  • FEDU 0.33
  • LEXX 0.06
  • MACD
  • FEDU 0.12
  • LEXX 0.02
  • Stochastic Oscillator
  • FEDU 90.77
  • LEXX 42.37

About FEDU FOUR SEASONS EDUCATION (CAYMAN) INC SPON ADS EACH REP 10 ORD SHS(R/S)

Four Seasons Education (Cayman) Inc is engaged in the provision of after-school education services for kindergarten, elementary and middle school students. The Company derives its revenue from learning services, tourism services, and learning technology and content solutions. The company is a comprehensive educational enterprise that provides research practice services, educational informatization equipment, high-quality educational resources, and teacher training, as well as a digital publishing business, and continues to expand in educational research and educational informatization.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

Share on Social Networks: